(Q34394916)

English

Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors

scientific article published on September 1, 2010

Statements

Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors (English)
Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-Adrenergic and Dopamine D1 Receptors (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit